| 1 |
metastatic colorectal cancer
(3141 times)
|
Neoplasms
(2080 times)
|
OS (974 times)
PFS (905 times)
EGFR (352 times)
|
1983 Computed tomography of calcified liver masses.
|
| 2 |
metastatic CRC
(219 times)
|
Neoplasms
(145 times)
|
CRC (192 times)
OS (45 times)
PFS (39 times)
|
2007 Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.
|
| 3 |
metastatic colorectal adenocarcinoma
(5 times)
|
Neoplasms
(4 times)
|
OS (3 times)
PFS (2 times)
CI (1 time)
|
2014 A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer.
|
| 4 |
metastatic colon cancer
(4 times)
|
Neoplasms
(3 times)
|
AD (1 time)
CI (1 time)
DVT (1 time)
|
2014 Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.
|
| 5 |
metastatic colorectal
(4 times)
|
Neoplasms
(4 times)
|
5-FUDR (1 time)
AIFA (1 time)
EGFR (1 time)
|
2014 Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
|
| 6 |
cancer metastases
(2 times)
|
Medicine
(1 time)
|
CCA (1 time)
HCC (1 time)
HR (1 time)
|
2020 Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis.
|
| 7 |
metastasized CRC
(2 times)
|
Neoplasms
(2 times)
|
CRC (2 times)
CIPN (1 time)
TEMs (1 time)
|
2016 Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response.
|
| 8 |
metastatic or advanced colorectal cancer
(2 times)
|
Antineoplastic Agents
(2 times)
|
BV (1 time)
mPFS (1 time)
|
2010 [Cetuximab for patients with metastatic colorectal cancer-from the result of recent clinical trials].
|
| 9 |
metastatic or unresectable colorectal cancer
(2 times)
|
Neoplasms
(2 times)
|
ORR (2 times)
CI (1 time)
EDM (1 time)
|
2020 A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
|
| 10 |
mainstay of treatment for solitary colorectal liver metastases
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2010 Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis.
|
| 11 |
major hepatic resection of colorectal liver metastases
(1 time)
|
Neoplasms
(1 time)
|
HAI (1 time)
PBL (1 time)
TEM (1 time)
|
2015 Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation.
|
| 12 |
metastases originating from colorectal cancer
(1 time)
|
|
AUC (1 time)
CART (1 time)
IOTA (1 time)
|
2019 Ultrasound and Clinical Preoperative Characteristics for Discrimination Between Ovarian Metastatic Colorectal Cancer and Primary Ovarian Cancer: A Case-Control Study.
|
| 13 |
metastasis of CRC
(1 time)
|
Hematology
(1 time)
|
CRC (1 time)
DFS (1 time)
HR (1 time)
|
2013 The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
|
| 14 |
metastatic carcinoma of the colon or rectum
(1 time)
|
Drug Therapy
(1 time)
|
MBC (1 time)
NSCLC (1 time)
|
2007 Bevacizumab: in first-line treatment of metastatic breast cancer.
|
| 15 |
metastatic colon cancer cells
(1 time)
|
Pharmacology
(1 time)
|
AGP (1 time)
CRC (1 time)
MLT (1 time)
|
2021 Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method.
|
| 16 |
metastatic colorectal cancer in the liver
(1 time)
|
Abdomen
(1 time)
|
mut (1 time)
PFS (1 time)
SIRT Y90 (1 time)
|
2016 Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.
|
| 17 |
metastatic colorectal cancer with potentially resectable liver metastases
(1 time)
|
Nuclear Medicine
(1 time)
|
PFS and OS (1 time)
SAM (1 time)
|
2013 Standardized added metabolic activity (SAM) IN ⁸F-FDG PET assessment of treatment response in colorectal liver metastases.
|
| 18 |
metastatic colorectal tumors
(1 time)
|
Neoplasms
(1 time)
|
ct (1 time)
|
2021 RAS Mutational Status in Advanced Colorectal Adenocarcinoma Treated With Anti-angiogenics: Preliminary Experience With Liquid Biopsy.
|
| 19 |
metastatic CRC cases
(1 time)
|
Neoplasms
(1 time)
|
AUC (1 time)
CRC (1 time)
dd-QMSP (1 time)
|
2019 Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer.
|
| 20 |
metastatic RAS wild-type colorectal cancer
(1 time)
|
Antineoplastic Agents
(1 time)
|
CL (1 time)
SD (1 time)
|
2013 Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report.
|
| 21 |
mucinous CRCs
(1 time)
|
Histocytochemistry
(1 time)
|
CRC (1 time)
SATB2 (1 time)
|
2017 A Comprehensive Evaluation of Special AT-rich Sequence-binding Protein 2 (SATB2) Immunohistochemical Staining in Mucinous Tumors From Gastrointestinal and Nongastrointestinal Sites.
|
| 22 |
non-metastatic CRC
(1 time)
|
Delivery of Health Care
(1 time)
|
CRC (1 time)
ICER (1 time)
WTP (1 time)
|
2018 Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations.
|
A Search Service for Abbreviation / Long Form